Informed consent and compulsory medical device registries: ethics and opportunities

Area of Science:

• Medical Device Regulation
• Clinical Research Ethics
• Cardiovascular Medicine

Background:

• High-risk medical devices in the US often receive marketing approval with limited premarket clinical data.
• Postmarket surveillance, including patient registries, is crucial for monitoring device performance and safety.
• Some cardiovascular device registries mandate enrollment for reimbursement without explicit patient informed consent.

Purpose of the Study:

• To examine the ethical obligation of cardiovascular device registries to obtain informed consent from enrollees.
• To identify potential losses incurred by not obtaining informed consent.
• To explore how informed consent processes could enhance US postmarket surveillance.

Main Methods:

• Ethical analysis of informed consent requirements in medical device registries.
• Review of current practices in prominent cardiovascular device registries.
• Discussion of the implications of consent for patient engagement and data quality.

Main Results:

• Registries may have an ethical duty to seek informed consent, beyond legal mandates.
• Lack of consent can lead to diminished patient autonomy and potential data limitations.
• Implementing informed consent can foster greater transparency and trust in postmarket surveillance.

Conclusions:

• Informed consent is ethically imperative for cardiovascular device registries, even when not legally required.
• Seeking consent can strengthen the integrity and effectiveness of postmarket surveillance systems.
• Ethical considerations in data collection are vital for patient safety and regulatory oversight.